Success Stories: EB-1A Approved for Research Scientist in New York in the Field of Molecular Biology
Client’s Testimonial:
I have good news to share. My I-140 got approved. I have uploaded a scan of the I-797, Notice of Action for your records. Great job on the RFE!!! [...] I have also gone to your law firm forum and posted a very positive review. Not a member of Immihelp and not familiar with other such sites. However, I have been and will continue to promote your firm by word-of-mouth. Two of my colleagues have been very impressed with my feedback and contacted your firm already. I encourage them with their process on a regular basis. Tomorrow I will share with them the good news of my approval.
On May 18th, 2015, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Research Scientist in the Field of Molecular Biology (Approval Notice)
Position at the Time of Case Filing: Research Scientist
Country of Origin: India
State of Residence at the Time of Filing: New York
Approval Notice Date: May 18th, 2015
Processing Time: 4 Months, 29 Days (Including RFE response time)
In this case, the client that we had the opportunity to work with was a Research Scientist from India in the field of Molecular Biology. His specialized research has focused on the development of anticancer agents and revealing/uncovering the oncological function of biological molecules. His work had resulted in 7 peer-reviewed scientific articles and numerous presentations at national and international conferences; at the time that his case was filed, his publications had been cited at least 139 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work. He had also reviewed 15 manuscripts for distinctive, internationally-circulated journals. His superior level of expertise was confirmed in the following quote from an independent recommender, “[Client]’s research has sustaining value to the medical community because of his commitment to providing new treatment options that specifically target the disease in question and are more effective overall than previous methods.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Molecular Biology, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 150 days.